$0.68
3.45% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US68247Q1022
Symbol
YI

111, Inc. Sponsored ADR Class A Stock price

$0.68
-0.41 37.34% 1M
-0.71 50.86% 6M
-0.87 55.94% YTD
-1.98 74.32% 1Y
-5.88 89.59% 3Y
-1.62 70.30% 5Y
-13.12 95.05% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
+0.02 3.45%
ISIN
US68247Q1022
Symbol
YI
Industry

Key metrics

Market capitalization $33.92m
Enterprise Value $101.74m
P/E (TTM) P/E ratio negative
EV/Sales (TTM) EV/Sales 0.05
P/S ratio (TTM) P/S ratio 0.02
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -3.29%
Revenue (TTM) Revenue $2.04b
EBIT (operating result TTM) EBIT $-38.66m
Cash position $84.71m
EPS (TTM) EPS $-0.54
P/S forward 0.02
EV/Sales forward 0.05
Short interest 0.01%
Show more

Is 111, Inc. Sponsored ADR Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

111, Inc. Sponsored ADR Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast 111, Inc. Sponsored ADR Class A:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast 111, Inc. Sponsored ADR Class A:

Buy
100%

Financial data from 111, Inc. Sponsored ADR Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,038 2,038
3% 3%
100%
- Direct Costs 1,924 1,924
3% 3%
94%
114 114
12% 12%
6%
- Selling and Administrative Expenses 137 137
8% 8%
7%
- Research and Development Expense 15 15
8% 8%
1%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -39 -39
6% 6%
-2%
Net Profit -46 -46
7% 7%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about 111, Inc. Sponsored ADR Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

111, Inc. Sponsored ADR Class A Stock News

Neutral
Seeking Alpha
9 days ago
111, Inc. (NASDAQ:YI ) Q2 2024 Earnings Conference Call August 29, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Conference Call Participants Xipeng Feng - CICC Zoe Bian - Citi Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the cal...
Neutral
PRNewsWire
10 days ago
Maintained Operational Profitability for the Second Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY Held Positive Operating Cash Flow for Two Consecutive Quarters SHANGHAI , Aug. 29, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of h...
Neutral
PRNewsWire
11 days ago
SHANGHAI , Aug. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst of Water Tower Research ("W...
More 111, Inc. Sponsored ADR Class A News

Company Profile

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment engages in the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

Head office Cayman Islands
CEO Jun Liu
Employees 1,520
Founded 2013
Website www.111.com.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today